Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Advances in newborn bloodspot screening

Israel, Janet Alice, Parsons, Evelyn Patricia and Bradley, Don M. 2006. Advances in newborn bloodspot screening. British Journal of Midwifery 14 (12) , pp. 702-705.

Full text not available from this repository.


This paper looks at the utilisation of tandem mass spectrometry (MS/MS) in newborn bloodspot screening. MS/MS has the ability to analyse a single blood sample for a relatively large number of neonatal disorders, including inborn errors of metabolism. It has therefore the capability to transform the face of newborn screening. In the UK medium chain acyl-coenzyme A dehydrogenase deficiency (MCADD) has been highlighted as a suitable candidate for screening using MS/MS but debates are still taking place about the disease process and the psychosocial implications of screening. Midwives are central to newborn screening and therefore any expansion of bloodspot screening would have implications for their practice in terms of information giving, parental consent and education. To ensure the continued success of newborn bloodspot screening it is important that midwives practice in accordance with professional standards, are aware of current developments and engage in debates prior to new service delivery implementation. The Department of Health and the National Screening Committee have undertaken a two year pilot study (2004–2006) looking at newborn screening for MCADD and their report, due out 2006/2007, has the potential to contribute constructively to current debates.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Healthcare Sciences
Subjects: R Medicine > RT Nursing
Publisher: Mark Allen Healthcare
ISSN: 0969-4900
Last Modified: 10 Jan 2018 07:34

Actions (repository staff only)

Edit Item Edit Item